CRC Research Update — October 14, 2026
Today's colorectal cancer research highlights
dmmr
A collection of 107 issues
CRC Research Update — October 11, 2026
Today's colorectal cancer research highlights
ATOMIC trial shows 86% three-year disease-free survival with atezolizumab combination
Skip to content
The CRC Digest
◆ TRIAL DATA
ATOMIC trial shows 86% three-year disease-free survival with atezolizumab combination
At a median follow-up of 40.9 months in the ATOMIC trial, the 3-year disease-free survival rate was 86.3% in patients receiving atezolizumab plus mFOLFOX6 compared with 76.2% in those
FDA approves atezolizumab plus chemotherapy for Stage III dMMR colon cancer
Skip to content
The CRC Digest
● REGULATORY
FDA approves atezolizumab plus chemotherapy for Stage III dMMR colon cancer
The FDA approved atezolizumab in combination with a fluoropyrimidine and oxaliplatin for adjuvant treatment of adult and pediatric patients two years and older with Stage III mismatch repair deficient colon cancer. Efficacy
CRC Research Update — October 10, 2026
Today's colorectal cancer research highlights
Chinese herbal formulation may shift pMMR tumors toward dMMR-like phenotype
Skip to content
The CRC Digest
◇ RESEARCH
Chinese herbal formulation may shift pMMR tumors toward dMMR-like phenotype
Preclinical research using mouse models found that Xian-Lian-Jie-Du decoction (XLJDD) may modulate proficient mismatch repair (pMMR) colorectal tumors toward a dMMR-like phenotype, potentially enhancing responsiveness to anti-PD-1 therapy. (Phytomedicine)
This content is informational
CRC Research Update — October 03, 2026
Today's colorectal cancer research highlights
MSI-H/dMMR prevalence varies by age and sex in Japanese cancer cohort
Skip to content
The CRC Digest
◇ RESEARCH
MSI-H/dMMR prevalence varies by age and sex in Japanese cancer cohort
Study of 1,130 older patients (median age 78) with gastric, colorectal, and endometrial cancers characterized deficient mismatch repair protein expression patterns, informing immunotherapy eligibility in aging populations. (Jpn J Clin
CRC Research Update — September 27, 2026
Today's colorectal cancer research highlights
CRC Research Update — September 23, 2026
Today's colorectal cancer research highlights